 |
| |
 |
| |
 |
| |
 |
A number of regenerative treatments are starting to be used in
human trials. The fields that are currently being developed to
promote tissue regeneration include mainly rehabilitation, protein
delivery (eg. scar digestive enzymes, inhibitors of growth
inhibitory factors or growth-promoting receptors) and stem cell
technologies, including the use of adult non-embryonic stem-
cells. Some of these treatments have reached the initial stages of
clinical trial studies, whilst nanomedicine or gene therapy
treatments are still being investigated in for pre-clinical
development.
Treatments that resemble naturally occurring tissue development
or regeneration will be presented at the start and end of the
books to emphasise the natural principles behind regenerative
medicine. The treatments will be assessed in terms of their
similarity to natural biological processes of the human body,
which are characterised by the interaction between three factors:
1. the origin of biological and biodegradable materials, whether
they are derived from the patient’s own body or from plants;
2. the simplicity of the treatment, including all the steps involved
in the treatment (for example obtaining stem cells from the patient’
s fat or blood and then increasing the number of stem cells via
the promotion of in vitro cell division, using, for instance, the
patient’s own natural growth factors and enzymes to differentiate
the cells until they reach the commitment step to become a
particular cell lineage);
3. the simplicity with which the tissue is re-implanted into the
patient’s damaged tissue (for example, ensuring that no life-
threatening operations are performed and the interventions do
not highly invade healthy body parts).
human trials. The fields that are currently being developed to
promote tissue regeneration include mainly rehabilitation, protein
delivery (eg. scar digestive enzymes, inhibitors of growth
inhibitory factors or growth-promoting receptors) and stem cell
technologies, including the use of adult non-embryonic stem-
cells. Some of these treatments have reached the initial stages of
clinical trial studies, whilst nanomedicine or gene therapy
treatments are still being investigated in for pre-clinical
development.
Treatments that resemble naturally occurring tissue development
or regeneration will be presented at the start and end of the
books to emphasise the natural principles behind regenerative
medicine. The treatments will be assessed in terms of their
similarity to natural biological processes of the human body,
which are characterised by the interaction between three factors:
1. the origin of biological and biodegradable materials, whether
they are derived from the patient’s own body or from plants;
2. the simplicity of the treatment, including all the steps involved
in the treatment (for example obtaining stem cells from the patient’
s fat or blood and then increasing the number of stem cells via
the promotion of in vitro cell division, using, for instance, the
patient’s own natural growth factors and enzymes to differentiate
the cells until they reach the commitment step to become a
particular cell lineage);
3. the simplicity with which the tissue is re-implanted into the
patient’s damaged tissue (for example, ensuring that no life-
threatening operations are performed and the interventions do
not highly invade healthy body parts).
Services of UR-REGENESIS
Applications of regenerative medicine on human
treatment
treatment
Maria Cristina Ovejero-Boglione
Deer losing & regenerating antlers
Stem cells differentiated into neurons
